# CB-17-08 Augmented Endoscopy System for Mucosal Lesion Detection During Colonoscopy for Colon Rectal Cancer.

> **NCT03954548** · NA · COMPLETED · sponsor: **Cosmo Artificial Intelligence-AI Ltd** · enrollment: 249 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DEVICE:** CB-17-08 CADe

## Key facts

- **NCT ID:** NCT03954548
- **Lead sponsor:** Cosmo Artificial Intelligence-AI Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-17
- **Primary completion:** 2021-05-07
- **Final completion:** 2021-05-07
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2021-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03954548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03954548, "CB-17-08 Augmented Endoscopy System for Mucosal Lesion Detection During Colonoscopy for Colon Rectal Cancer.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03954548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*